Poor
Not Aligned
Patient Risk:
Moderate
Summary
Only a subset of Lyrica-related claims (indications and the warning statements on dizziness/somnolence and weight gain) are supported by the provided label sections. Most other claims (mechanisms and virtually all supplement/CBD/GABA/5-HTP/magnesium/ashwagandha and comparative effectiveness statements) are not supported within the provided label scope and may be misleading. The epilepsy claim is also broader than the label supports.
Category Scores
Accurate Statements
Lyrica is a prescription medication used to treat fibromyalgia.
1 INDICATIONS AND USAGE: “Management of fibromyalgia”
Lyrica is a prescription medication used to treat neuropathic pain.
1 INDICATIONS AND USAGE: “Management of neuropathic pain associated with diabetic peripheral neuropathy” (also includes postherpetic neuralgia and neuropathic pain associated with spinal cord injury)
Lyrica can cause dizziness.
5 WARNINGS AND PRECAUTIONS (5.5 Dizziness and Somnolence): “LYRICA may cause dizziness and somnolence.”
Lyrica can cause weight gain.
5 WARNINGS AND PRECAUTIONS (5.8 Weight Gain): “LYRICA treatment may cause weight gain.”
Unsupported Statements
Lyrica is also known as pregabalin.
Not supported in the provided label sections.
Ashwagandha is an herb used in Ayurvedic medicine to treat anxiety and stress.
Not supported in the provided label sections.
GABA is a neurotransmitter that helps regulate sleep and relaxation.
Not supported in the provided label sections.
5-HTP is an amino acid that helps regulate mood and sleep.
Not supported in the provided label sections.
Magnesium is a mineral that helps relax muscles and reduce pain.
Not supported in the provided label sections.
CBD oil is a non-psychoactive compound found in cannabis plants.
Not supported in the provided label sections.
CBD oil has anti-inflammatory properties.
Not supported in the provided label sections.
CBD oil has pain-relieving properties.
Not supported in the provided label sections.
Ashwagandha can reduce anxiety and stress by increasing GABA levels in the brain.
Not supported in the provided label sections.
GABA has a calming effect on the nervous system.
Not supported in the provided label sections.
The calming effect of GABA can help reduce anxiety.
Not supported in the provided label sections.
GABA can promote relaxation.
Not supported in the provided label sections.
5-HTP increases serotonin levels in the brain.
Not supported in the provided label sections.
Increased serotonin levels from 5-HTP can help regulate mood.
Not supported in the provided label sections.
Increased serotonin levels from 5-HTP can help reduce symptoms of depression.
Not supported in the provided label sections.
Magnesium relaxes muscles and reduces pain.
Not supported in the provided label sections.
Magnesium reduces pain by blocking the release of pain-causing chemicals.
Not supported in the provided label sections.
CBD oil has anti-inflammatory and pain-relieving properties.
Not supported in the provided label sections.
In patients with generalized anxiety disorder, ashwagandha was as effective as Lyrica in reducing anxiety and stress.
Not supported in the provided label sections.
In patients with fibromyalgia, CBD oil was not as effective as Lyrica in reducing pain.
Not supported in the provided label sections.
Natural Lyrica alternatives may not be as effective as Lyrica for everyone.
Not supported in the provided label sections.
Natural Lyrica alternatives can interact with other medications, including Lyrica.
Not supported in the provided label sections.
Natural Lyrica alternatives may take longer to work than Lyrica.
Not supported in the provided label sections.
Natural Lyrica alternatives can have side effects.
Not supported in the provided label sections.
Natural Lyrica alternatives are generally considered safe.
Not supported in the provided label sections.
Natural Lyrica alternatives are not regulated by the FDA.
Not supported in the provided label sections.
Natural Lyrica alternatives are subject to Good Manufacturing Practice (GMP) regulations.
Not supported in the provided label sections.
Contradictions
Important Omissions
Dosage and administration details (not provided in the scoped label sections).
Importance:
Moderate
Contraindications and boxed warnings (not provided in the scoped label sections).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported claims about supplements/CBD and comparative effectiveness/safety could mislead relative to labeled Lyrica use. Within the provided label scope, Lyrica dizziness/somnolence and weight gain claims are supported.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Many statements are not supported by the provided FDA label sections (especially all supplement/CBD/ingredient mechanism and comparative effectiveness claims), and the epilepsy wording is broader than the label’s “adjunctive therapy for partial-onset seizures.”
Suggested Improvement
Limit statements to what is supported by the provided label sections: correct indications to match labeled wording (e.g., partial-onset seizures adjunctive therapy rather than generalized “epilepsy”), retain only label-supported adverse effects (dizziness/somnolence, weight gain), and remove or clearly separate any non-label supplement/CBD/mechanism/comparative effectiveness claims.